CHAMPIONS ONCOLOGY, INC. Related Party Transaction, Amounts of Transaction
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Related Party Transaction, Amounts of Transaction of $0 for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. related party transaction, amounts of transaction for the quarter ending 2026-07-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. related party transaction, amounts of transaction for the quarter ending 2025-07-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. related party transaction, amounts of transaction for the quarter ending 2015-07-31 was $18.00K, a 52.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. related party transaction, amounts of transaction for the quarter ending 2015-01-31 was $0.00, a 100.00% decline year-over-year.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 9 month |
|---|---|---|---|
| 2026-07-31 | $0.00 10-Q · filed 2026-09-11 | ||
| 2025-07-31 | $0.00 10-Q · filed 2026-09-11 | ||
| 2015-07-31 | $18.00K 10-Q · filed 2015-09-11 | ||
| 2015-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $37.50K derived: sum of 2 quarters · filed 2015-03-17 | $75.00K 10-Q · filed 2015-03-17 |
| 2014-10-31 | $37.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $75.00K 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $37.50K 10-Q · filed 2015-09-11 | ||
| 2014-01-31 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $115.00K 10-Q · filed 2015-03-17 | |
| 2013-10-31 | $75.00K 10-Q · filed 2014-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |